ONTOLOGY REPORT - ANNOTATIONS
| Term: | 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one |
|
| Accession: | CHEBI:32692
|
browse the term
|
| Definition: | A nitrosamine that has formula C10H13N3O2. |
| Synonyms: | exact_synonym: | 4-[methyl(nitroso)amino]-1-(pyridin-3-yl)butan-1-one |
| | related_synonym: | 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone; 4-(N-Methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone; C10H13N3O2; CN(CCCC(=O)c1cccnc1)N=O; InChI=1S/C10H13N3O2/c1-13(12-15)7-3-5-10(14)9-4-2-6-11-8-9/h2,4,6,8H,3,5,7H2,1H3; InChIKey=FLAQQSHRLBFIEZ-UHFFFAOYSA-N; NNK (carcinogen) |
| | xref_casrn: | 64091-91-4 |
| | xref: | ChemIDplus:3548355 "Beilstein Registry Number"; ChemIDplus:64091-91-4 "CAS Registry Number" |
| | xref_mesh: | MESH:C016583 |
|
|
4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one
|
| G |
ABCC2 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
|
affects abundance |
ISO |
10 |
101,542,463 |
101,611,662 |
RGD:6480464 |
CTD |
| G |
ACO1 |
aconitase 1, soluble |
|
increases expression |
ISO |
9 |
32,384,601 |
32,450,834 |
RGD:6480464 |
CTD |
| G |
ACSL1 |
acyl-CoA synthetase long-chain family member 1 |
|
multiple interactions |
EXP |
4 |
185,676,749 |
185,747,215 |
RGD:6480464 |
CTD |
| G |
AGPAT1 |
1-acylglycerol-3-phosphate O-acyltransferase 1 |
|
multiple interactions |
EXP |
6 |
32,135,983 |
32,145,888 |
RGD:6480464 |
CTD |
| G |
AIF1 |
allograft inflammatory factor 1 |
|
increases expression |
ISO |
6 |
31,582,994 |
31,584,798 |
RGD:6480464 |
CTD |
| G |
AKR1C1 |
aldo-keto reductase family 1, member C1 |
|
increases metabolic processing |
EXP |
10 |
5,005,454 |
5,020,158 |
RGD:6480464 |
CTD |
| G |
AKR1C2 |
aldo-keto reductase family 1, member C2 |
|
increases metabolic processing |
EXP |
10 |
5,029,967 |
5,060,225 |
RGD:6480464 |
CTD |
| G |
AKR1C4 |
aldo-keto reductase family 1, member C4 |
|
increases metabolic processing |
EXP |
10 |
5,238,798 |
5,260,910 |
RGD:6480464 |
CTD |
| G |
AKR7A3 |
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) |
|
increases expression |
ISO |
1 |
19,609,057 |
19,615,280 |
RGD:6480464 |
CTD |
| G |
AKR7A3 |
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) |
|
increases expression |
ISO |
1 |
19,609,057 |
19,615,280 |
RGD:6480464 |
CTD |
| G |
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
14 |
105,235,686 |
105,262,080 |
RGD:6480464 |
CTD |
| G |
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
14 |
105,235,686 |
105,262,080 |
RGD:6480464 |
CTD |
| G |
ALDH1A1 |
aldehyde dehydrogenase 1 family, member A1 |
|
increases expression |
ISO |
9 |
75,515,578 |
75,568,233 |
RGD:6480464 |
CTD |
| G |
ALDH1A1 |
aldehyde dehydrogenase 1 family, member A1 |
|
increases expression |
ISO |
9 |
75,515,578 |
75,568,233 |
RGD:6480464 |
CTD |
| G |
ALDH1A1 |
aldehyde dehydrogenase 1 family, member A1 |
|
increases expression |
ISO |
9 |
75,515,578 |
75,568,233 |
RGD:6480464 |
CTD |
| G |
ALDH7A1 |
aldehyde dehydrogenase 7 family, member A1 |
|
increases expression |
EXP |
5 |
125,877,533 |
125,931,082 |
RGD:6480464 |
CTD |
| G |
ANXA2 |
annexin A2 |
|
increases expression |
ISO |
15 |
60,639,350 |
60,690,185 |
RGD:6480464 |
CTD |
| G |
APEX1 |
APEX nuclease (multifunctional DNA repair enzyme) 1 |
|
increases expression |
ISO |
14 |
20,923,290 |
20,925,931 |
RGD:6480464 |
CTD |
| G |
APH1B |
anterior pharynx defective 1 homolog B (C. elegans) |
|
increases expression |
ISO |
15 |
63,569,749 |
63,601,325 |
RGD:6480464 |
CTD |
| G |
ARID4B |
AT rich interactive domain 4B (RBP1-like) |
|
multiple interactions |
EXP |
1 |
235,330,210 |
235,491,532 |
RGD:6480464 |
CTD |
| G |
ASL |
argininosuccinate lyase |
|
increases expression |
EXP |
7 |
65,540,776 |
65,558,330 |
RGD:6480464 |
CTD |
| G |
ATF1 |
activating transcription factor 1 |
|
increases phosphorylation |
EXP |
12 |
51,157,789 |
51,214,943 |
RGD:6480464 |
CTD |
| G |
ATF1 |
activating transcription factor 1 |
|
multiple interactions |
EXP |
12 |
51,157,789 |
51,214,943 |
RGD:6480464 |
CTD |
| G |
ATF3 |
activating transcription factor 3 |
|
increases expression |
ISO |
1 |
212,738,676 |
212,794,119 |
RGD:6480464 |
CTD |
| G |
ATM |
ataxia telangiectasia mutated |
|
multiple interactions |
EXP |
11 |
108,093,559 |
108,239,826 |
RGD:6480464 |
CTD |
| G |
ATP5G1 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9) |
|
decreases expression |
ISO |
17 |
46,970,148 |
46,973,233 |
RGD:6480464 |
CTD |
| G |
ATP6V1D |
ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D |
|
increases expression |
ISO |
14 |
67,804,581 |
67,826,720 |
RGD:6480464 |
CTD |
| G |
ATP6V1D |
ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D |
|
increases expression |
ISO |
14 |
67,804,581 |
67,826,720 |
RGD:6480464 |
CTD |
| G |
ATP6V1D |
ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D |
|
increases expression |
ISO |
14 |
67,804,581 |
67,826,720 |
RGD:6480464 |
CTD |
| G |
B4GALT1 |
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
|
multiple interactions |
EXP |
9 |
33,110,639 |
33,167,356 |
RGD:6480464 |
CTD |
| G |
BAD |
BCL2-associated agonist of cell death |
|
decreases expression |
EXP |
11 |
64,037,300 |
64,052,176 |
RGD:6480464 |
CTD |
| G |
BAD |
BCL2-associated agonist of cell death |
|
multiple interactions |
EXP |
11 |
64,037,300 |
64,052,176 |
RGD:6480464 |
CTD |
| G |
BARHL1 |
BarH-like homeobox 1 |
|
multiple interactions |
EXP |
9 |
135,457,993 |
135,465,640 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
increases expression |
ISO |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
increases expression |
ISO |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
multiple interactions |
EXP |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
increases expression |
ISO |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
increases expression |
ISO |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
EXP |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
EXP |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
EXP |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
EXP |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BHMT |
betaine--homocysteine S-methyltransferase |
|
decreases expression |
ISO |
5 |
78,407,604 |
78,428,113 |
RGD:6480464 |
CTD |
| G |
BIRC3 |
baculoviral IAP repeat containing 3 |
|
increases expression |
EXP |
11 |
102,188,181 |
102,210,134 |
RGD:6480464 |
CTD |
| G |
BIRC3 |
baculoviral IAP repeat containing 3 |
|
multiple interactions |
EXP |
11 |
102,188,181 |
102,210,134 |
RGD:6480464 |
CTD |
| G |
BIRC5 |
baculoviral IAP repeat containing 5 |
|
decreases expression |
ISO |
17 |
76,210,277 |
76,221,716 |
RGD:6480464 |
CTD |
| G |
BIRC5 |
baculoviral IAP repeat containing 5 |
|
multiple interactions |
EXP |
17 |
76,210,277 |
76,221,716 |
RGD:6480464 |
CTD |
| G |
BOLA3 |
bolA homolog 3 (E. coli) |
|
multiple interactions |
EXP |
2 |
74,362,528 |
74,375,039 |
RGD:6480464 |
CTD |
| G |
BRCA1 |
breast cancer 1, early onset |
|
increases expression |
ISO |
17 |
41,196,312 |
41,277,500 |
RGD:6480464 |
CTD |
| G |
BRCA1 |
breast cancer 1, early onset |
|
multiple interactions |
ISO |
17 |
41,196,312 |
41,277,500 |
RGD:6480464 |
CTD |
| G |
BTG2 |
BTG family, member 2 |
|
increases expression |
ISO |
1 |
203,274,664 |
203,278,730 |
RGD:6480464 |
CTD |
| G |
BTG2 |
BTG family, member 2 |
|
increases expression |
ISO |
1 |
203,274,664 |
203,278,730 |
RGD:6480464 |
CTD |
| G |
BTG2 |
BTG family, member 2 |
|
increases expression |
ISO |
1 |
203,274,664 |
203,278,730 |
RGD:6480464 |
CTD |
| G |
BTG2 |
BTG family, member 2 |
|
increases expression |
ISO |
1 |
203,274,664 |
203,278,730 |
RGD:6480464 |
CTD |
| G |
BTG3 |
BTG family, member 3 |
|
increases expression |
ISO |
21 |
18,965,968 |
18,985,268 |
RGD:6480464 |
CTD |
| G |
BTG3 |
BTG family, member 3 |
|
increases expression |
ISO |
21 |
18,965,968 |
18,985,268 |
RGD:6480464 |
CTD |
| G |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
|
increases expression |
ISO |
2 |
202,098,166 |
202,152,434 |
RGD:6480464 |
CTD |
| G |
CBR1 |
carbonyl reductase 1 |
|
multiple interactions |
EXP |
21 |
37,442,285 |
37,445,462 |
RGD:6480464 |
CTD |
| G |
CBR1 |
carbonyl reductase 1 |
|
increases metabolic processing |
EXP |
21 |
37,442,285 |
37,445,462 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
decreases expression |
EXP |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCNB1 |
cyclin B1 |
|
decreases expression |
ISO |
5 |
68,462,837 |
68,474,072 |
RGD:6480464 |
CTD |
| G |
CCND1 |
cyclin D1 |
|
multiple interactions |
EXP |
11 |
69,455,873 |
69,469,242 |
RGD:6480464 |
CTD |
| G |
CCND1 |
cyclin D1 |
|
increases expression |
ISO |
11 |
69,455,873 |
69,469,242 |
RGD:6480464 |
CTD |
| G |
CCND1 |
cyclin D1 |
|
increases expression |
EXP |
11 |
69,455,873 |
69,469,242 |
RGD:6480464 |
CTD |
| G |
CCND1 |
cyclin D1 |
|
increases expression |
ISO |
11 |
69,455,873 |
69,469,242 |
RGD:6480464 |
CTD |
| G |
CCND1 |
cyclin D1 |
|
increases expression |
ISO |
11 |
69,455,873 |
69,469,242 |
RGD:6480464 |
CTD |
| G |
CCNG1 |
cyclin G1 |
|
increases expression |
ISO |
5 |
162,864,577 |
162,872,022 |
RGD:6480464 |
CTD |
| G |
CCNG1 |
cyclin G1 |
|
increases expression |
ISO |
5 |
162,864,577 |
162,872,022 |
RGD:6480464 |
CTD |
| G |
CCNG1 |
cyclin G1 |
|
increases expression |
ISO |
5 |
162,864,577 |
162,872,022 |
RGD:6480464 |
CTD |
| G |
CCNG1 |
cyclin G1 |
|
increases expression |
ISO |
5 |
162,864,577 |
162,872,022 |
RGD:6480464 |
CTD |
| G |
CCT3 |
chaperonin containing TCP1, subunit 3 (gamma) |
|
increases expression |
ISO |
1 |
156,278,752 |
156,308,206 |
RGD:6480464 |
CTD |
| G |
CDC20 |
cell division cycle 20 |
|
decreases expression |
ISO |
1 |
43,824,626 |
43,828,874 |
RGD:6480464 |
CTD |
| G |
CDK1 |
cyclin-dependent kinase 1 |
|
decreases expression |
ISO |
10 |
62,538,089 |
62,554,610 |
RGD:6480464 |
CTD |
| G |
CDK16 |
cyclin-dependent kinase 16 |
|
increases expression |
ISO |
X |
47,077,528 |
47,089,396 |
RGD:6480464 |
CTD |
| G |
CDK4 |
cyclin-dependent kinase 4 |
|
increases expression |
ISO |
12 |
58,141,510 |
58,146,230 |
RGD:6480464 |
CTD |
| G |
CDK4 |
cyclin-dependent kinase 4 |
|
multiple interactions |
EXP |
12 |
58,141,510 |
58,146,230 |
RGD:6480464 |
CTD |
| G |
CDK4 |
cyclin-dependent kinase 4 |
|
increases expression |
ISO |
12 |
58,141,510 |
58,146,230 |
RGD:6480464 |
CTD |
| G |
CDK6 |
cyclin-dependent kinase 6 |
|
multiple interactions |
EXP |
7 |
92,234,235 |
92,465,941 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
increases expression |
ISO |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
increases expression |
EXP |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
multiple interactions |
EXP |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
multiple interactions |
EXP |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
decreases expression |
EXP |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
decreases expression |
ISO |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
increases expression |
ISO |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
increases expression |
ISO |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
increases expression |
ISO |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1B |
cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
|
decreases expression |
EXP |
12 |
12,870,302 |
12,875,305 |
RGD:6480464 |
CTD |
| G |
CDKN1B |
cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
|
multiple interactions |
EXP |
12 |
12,870,302 |
12,875,305 |
RGD:6480464 |
CTD |
| G |
CDKN2A |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
ISO |
9 |
21,967,751 |
21,994,490 |
RGD:6480464 |
CTD |
| G |
CES2 |
carboxylesterase 2 |
|
increases expression |
ISO |
16 |
66,968,347 |
66,978,999 |
RGD:6480464 |
CTD |
| G |
CES2 |
carboxylesterase 2 |
|
increases expression |
ISO |
16 |
66,968,347 |
66,978,999 |
RGD:6480464 |
CTD |
| G |
CGREF1 |
cell growth regulator with EF-hand domain 1 |
|
increases expression |
ISO |
2 |
27,322,221 |
27,341,995 |
RGD:6480464 |
CTD |
| G |
CGREF1 |
cell growth regulator with EF-hand domain 1 |
|
increases expression |
ISO |
2 |
27,322,221 |
27,341,995 |
RGD:6480464 |
CTD |
| G |
CGREF1 |
cell growth regulator with EF-hand domain 1 |
|
increases expression |
ISO |
2 |
27,322,221 |
27,341,995 |
RGD:6480464 |
CTD |
| G |
CGREF1 |
cell growth regulator with EF-hand domain 1 |
|
increases expression |
ISO |
2 |
27,322,221 |
27,341,995 |
RGD:6480464 |
CTD |
| G |
CGRRF1 |
cell growth regulator with ring finger domain 1 |
|
increases expression |
ISO |
14 |
54,976,587 |
55,005,334 |
RGD:6480464 |
CTD |
| G |
CHD1L |
chromodomain helicase DNA binding protein 1-like |
|
increases expression |
EXP |
1 |
146,714,291 |
146,767,447 |
RGD:6480464 |
CTD |
| G |
CHRNA7 |
cholinergic receptor, nicotinic, alpha 7 (neuronal) |
|
increases activity |
EXP |
15 |
32,322,686 |
32,462,384 |
RGD:6480464 |
CTD |
| G |
CHRNA7 |
cholinergic receptor, nicotinic, alpha 7 (neuronal) |
|
increases expression |
EXP |
15 |
32,322,686 |
32,462,384 |
RGD:6480464 |
CTD |
| G |
CHRNA7 |
cholinergic receptor, nicotinic, alpha 7 (neuronal) |
|
affects binding |
EXP |
15 |
32,322,686 |
32,462,384 |
RGD:6480464 |
CTD |
| G |
CNTN1 |
contactin 1 |
|
multiple interactions |
EXP |
12 |
41,086,244 |
41,466,214 |
RGD:6480464 |
CTD |
| G |
CNTN1 |
contactin 1 |
|
increases expression |
EXP |
12 |
41,086,244 |
41,466,214 |
RGD:6480464 |
CTD |
| G |
COMMD1 |
copper metabolism (Murr1) domain containing 1 |
|
increases expression |
EXP |
2 |
62,132,803 |
62,363,205 |
RGD:6480464 |
CTD |
| G |
COX17 |
cytochrome c oxidase assembly homolog 17 (yeast) |
|
multiple interactions |
EXP |
3 |
119,388,372 |
119,396,243 |
RGD:6480464 |
CTD |
| G |
CR1L |
complement component (3b/4b) receptor 1-like |
|
increases expression |
ISO |
1 |
207,818,458 |
207,897,036 |
RGD:6480464 |
CTD |
| G |
CR1L |
complement component (3b/4b) receptor 1-like |
|
increases expression |
ISO |
1 |
207,818,458 |
207,897,036 |
RGD:6480464 |
CTD |
| G |
CREB1 |
cAMP responsive element binding protein 1 |
|
increases phosphorylation |
EXP |
2 |
208,394,616 |
208,470,284 |
RGD:6480464 |
CTD |
| G |
CREB1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
EXP |
2 |
208,394,616 |
208,470,284 |
RGD:6480464 |
CTD |
| G |
CRYAB |
crystallin, alpha B |
|
increases expression |
ISO |
11 |
111,779,350 |
111,782,473 |
RGD:6480464 |
CTD |
| G |
CSTB |
cystatin B (stefin B) |
|
increases expression |
ISO |
21 |
45,193,546 |
45,196,256 |
RGD:6480464 |
CTD |
| G |
CTSD |
cathepsin D |
|
increases expression |
ISO |
11 |
1,773,982 |
1,785,222 |
RGD:6480464 |
CTD |
| G |
CTSS |
cathepsin S |
|
increases expression |
ISO |
1 |
150,702,672 |
150,738,433 |
RGD:6480464 |
CTD |
| G |
CXCL10 |
chemokine (C-X-C motif) ligand 10 |
|
increases expression |
ISO |
4 |
76,942,269 |
76,944,689 |
RGD:6480464 |
CTD |
| G |
CXCL10 |
chemokine (C-X-C motif) ligand 10 |
|
increases expression |
ISO |
4 |
76,942,269 |
76,944,689 |
RGD:6480464 |
CTD |
| G |
CYB5A |
cytochrome b5 type A (microsomal) |
|
multiple interactions |
EXP |
18 |
71,920,527 |
71,959,251 |
RGD:6480464 |
CTD |
| G |
CYB5R3 |
cytochrome b5 reductase 3 |
|
decreases expression |
ISO |
22 |
43,013,846 |
43,045,405 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
increases expression |
ISO |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A2 |
cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
multiple interactions |
EXP |
15 |
75,041,184 |
75,048,941 |
RGD:6480464 |
CTD |
| G |
CYP1A2 |
cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
increases activity |
EXP |
15 |
75,041,184 |
75,048,941 |
RGD:6480464 |
CTD |
| G |
CYP1B1 |
cytochrome P450, family 1, subfamily B, polypeptide 1 |
|
multiple interactions |
EXP |
2 |
38,294,746 |
38,303,323 |
RGD:6480464 |
CTD |
| G |
CYP1B1 |
cytochrome P450, family 1, subfamily B, polypeptide 1 |
|
multiple interactions |
EXP |
2 |
38,294,746 |
38,303,323 |
RGD:6480464 |
CTD |
| G |
CYP2A13 |
cytochrome P450, family 2, subfamily A, polypeptide 13 |
|
affects metabolic processing |
EXP |
19 |
41,594,356 |
41,602,100 |
RGD:6480464 |
CTD |
| G |
CYP2A13 |
cytochrome P450, family 2, subfamily A, polypeptide 13 |
|
multiple interactions |
EXP |
19 |
41,594,356 |
41,602,100 |
RGD:6480464 |
CTD |
| G |
CYP2A13 |
cytochrome P450, family 2, subfamily A, polypeptide 13 |
|
affects metabolic processing |
EXP |
19 |
41,594,356 |
41,602,100 |
RGD:6480464 |
CTD |
| G |
CYP2A13 |
cytochrome P450, family 2, subfamily A, polypeptide 13 |
|
decreases hydroxylation |
EXP |
19 |
41,594,356 |
41,602,100 |
RGD:6480464 |
CTD |
| G |
CYP2A13 |
cytochrome P450, family 2, subfamily A, polypeptide 13 |
|
affects metabolic processing |
EXP |
19 |
41,594,356 |
41,602,100 |
RGD:6480464 |
CTD |
| G |
CYP2A13 |
cytochrome P450, family 2, subfamily A, polypeptide 13 |
|
multiple interactions |
EXP |
19 |
41,594,356 |
41,602,100 |
RGD:6480464 |
CTD |
| G |
CYP2A13 |
cytochrome P450, family 2, subfamily A, polypeptide 13 |
|
increases metabolic processing |
EXP |
19 |
41,594,356 |
41,602,100 |
RGD:6480464 |
CTD |
| G |
CYP2A13 |
cytochrome P450, family 2, subfamily A, polypeptide 13 |
|
increases hydroxylation |
EXP |
19 |
41,594,356 |
41,602,100 |
RGD:6480464 |
CTD |
| G |
CYP2A13 |
cytochrome P450, family 2, subfamily A, polypeptide 13 |
|
decreases metabolic processing |
EXP |
19 |
41,594,356 |
41,602,100 |
RGD:6480464 |
CTD |
| G |
CYP2A13 |
cytochrome P450, family 2, subfamily A, polypeptide 13 |
|
multiple interactions |
EXP |
19 |
41,594,356 |
41,602,100 |
RGD:6480464 |
CTD |
| G |
CYP2A13 |
cytochrome P450, family 2, subfamily A, polypeptide 13 |
|
affects metabolic processing |
EXP |
19 |
41,594,356 |
41,602,100 |
RGD:6480464 |
CTD |
| G |
CYP2A13 |
cytochrome P450, family 2, subfamily A, polypeptide 13 |
|
multiple interactions |
EXP |
19 |
41,594,356 |
41,602,100 |
RGD:6480464 |
CTD |
| G |
CYP2A13 |
cytochrome P450, family 2, subfamily A, polypeptide 13 |
|
affects metabolic processing |
EXP |
19 |
41,594,356 |
41,602,100 |
RGD:6480464 |
CTD |
| G |
CYP2A13 |
cytochrome P450, family 2, subfamily A, polypeptide 13 |
|
multiple interactions |
EXP |
19 |
41,594,356 |
41,602,100 |
RGD:6480464 |
CTD |
| G |
CYP2A13 |
cytochrome P450, family 2, subfamily A, polypeptide 13 |
|
increases hydroxylation |
EXP |
19 |
41,594,356 |
41,602,100 |
RGD:6480464 |
CTD |
| G |
CYP2A13 |
cytochrome P450, family 2, subfamily A, polypeptide 13 |
|
increases activity |
EXP |
19 |
41,594,356 |
41,602,100 |
RGD:6480464 |
CTD |
| G |
CYP2A13 |
cytochrome P450, family 2, subfamily A, polypeptide 13 |
|
affects metabolic processing |
EXP |
19 |
41,594,356 |
41,602,100 |
RGD:6480464 |
CTD |
| G |
CYP2A13 |
cytochrome P450, family 2, subfamily A, polypeptide 13 |
|
multiple interactions |
EXP |
19 |
41,594,356 |
41,602,100 |
RGD:6480464 |
CTD |
| G |
CYP2A6 |
cytochrome P450, family 2, subfamily A, polypeptide 6 |
|
increases metabolic processing |
EXP |
19 |
41,349,443 |
41,356,352 |
RGD:6480464 |
CTD |
| G |
CYP2A6 |
cytochrome P450, family 2, subfamily A, polypeptide 6 |
|
multiple interactions |
EXP |
19 |
41,349,443 |
41,356,352 |
RGD:6480464 |
CTD |
| G |
CYP2A6 |
cytochrome P450, family 2, subfamily A, polypeptide 6 |
|
multiple interactions |
EXP |
19 |
41,349,443 |
41,356,352 |
RGD:6480464 |
CTD |
| G |
CYP2A6 |
cytochrome P450, family 2, subfamily A, polypeptide 6 |
|
multiple interactions |
EXP |
19 |
41,349,443 |
41,356,352 |
RGD:6480464 |
CTD |
| G |
CYP2A6 |
cytochrome P450, family 2, subfamily A, polypeptide 6 |
|
affects metabolic processing |
EXP |
19 |
41,349,443 |
41,356,352 |
RGD:6480464 |
CTD |
| G |
CYP2A6 |
cytochrome P450, family 2, subfamily A, polypeptide 6 |
|
multiple interactions |
EXP |
19 |
41,349,443 |
41,356,352 |
RGD:6480464 |
CTD |
| G |
CYP2A6 |
cytochrome P450, family 2, subfamily A, polypeptide 6 |
|
increases metabolic processing |
EXP |
19 |
41,349,443 |
41,356,352 |
RGD:6480464 |
CTD |
| G |
CYP2A6 |
cytochrome P450, family 2, subfamily A, polypeptide 6 |
|
increases activity |
EXP |
19 |
41,349,443 |
41,356,352 |
RGD:6480464 |
CTD |
| G |
CYP2A6 |
cytochrome P450, family 2, subfamily A, polypeptide 6 |
|
multiple interactions |
EXP |
19 |
41,349,443 |
41,356,352 |
RGD:6480464 |
CTD |
| G |
CYP2A6 |
cytochrome P450, family 2, subfamily A, polypeptide 6 |
|
increases metabolic processing |
EXP |
19 |
41,349,443 |
41,356,352 |
RGD:6480464 |
CTD |
| G |
CYP2A6 |
cytochrome P450, family 2, subfamily A, polypeptide 6 |
|
multiple interactions |
EXP |
19 |
41,349,443 |
41,356,352 |
RGD:6480464 |
CTD |
| G |
CYP2A6 |
cytochrome P450, family 2, subfamily A, polypeptide 6 |
|
multiple interactions |
EXP |
19 |
41,349,443 |
41,356,352 |
RGD:6480464 |
CTD |
| G |
CYP2A6 |
cytochrome P450, family 2, subfamily A, polypeptide 6 |
|
increases metabolic processing |
EXP |
19 |
41,349,443 |
41,356,352 |
RGD:6480464 |
CTD |
| G |
CYP2A6 |
cytochrome P450, family 2, subfamily A, polypeptide 6 |
|
multiple interactions |
EXP |
19 |
41,349,443 |
41,356,352 |
RGD:6480464 |
CTD |
| G |
CYP2A6 |
cytochrome P450, family 2, subfamily A, polypeptide 6 |
|
increases metabolic processing |
EXP |
19 |
41,349,443 |
41,356,352 |
RGD:6480464 |
CTD |
| G |
CYP2A6 |
cytochrome P450, family 2, subfamily A, polypeptide 6 |
|
increases hydroxylation |
EXP |
19 |
41,349,443 |
41,356,352 |
RGD:6480464 |
CTD |
| G |
CYP2A6 |
cytochrome P450, family 2, subfamily A, polypeptide 6 |
|
increases activity |
EXP |
19 |
41,349,443 |
41,356,352 |
RGD:6480464 |
CTD |
| G |
CYP2A6 |
cytochrome P450, family 2, subfamily A, polypeptide 6 |
|
multiple interactions |
EXP |
19 |
41,349,443 |
41,356,352 |
RGD:6480464 |
CTD |
| G |
CYP2B6 |
cytochrome P450, family 2, subfamily B, polypeptide 6 |
|
affects metabolic processing |
EXP |
19 |
41,497,204 |
41,524,301 |
RGD:6480464 |
CTD |
| G |
CYP2B6 |
cytochrome P450, family 2, subfamily B, polypeptide 6 |
|
increases activity |
EXP |
19 |
41,497,204 |
41,524,301 |
RGD:6480464 |
CTD |
| G |
CYP2C19 |
cytochrome P450, family 2, subfamily C, polypeptide 19 |
|
multiple interactions |
EXP |
10 |
96,522,463 |
96,612,671 |
RGD:6480464 |
CTD |
| G |
CYP2D6 |
cytochrome P450, family 2, subfamily D, polypeptide 6 |
|
increases metabolic processing |
EXP |
22 |
42,522,501 |
42,526,883 |
RGD:6480464 |
CTD |
| G |
CYP2E1 |
cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
affects metabolic processing |
EXP |
10 |
135,340,867 |
135,352,620 |
RGD:6480464 |
CTD |
| G |
CYP2E1 |
cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
increases activity |
ISO |
10 |
135,340,867 |
135,352,620 |
RGD:6480464 |
CTD |
| G |
CYP2E1 |
cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
increases metabolic processing |
EXP |
10 |
135,340,867 |
135,352,620 |
RGD:6480464 |
CTD |
| G |
CYP3A4 |
cytochrome P450, family 3, subfamily A, polypeptide 4 |
|
increases metabolic processing |
EXP |
7 |
99,354,583 |
99,381,811 |
RGD:6480464 |
CTD |
| G |
CYP3A4 |
cytochrome P450, family 3, subfamily A, polypeptide 4 |
|
multiple interactions |
EXP |
7 |
99,354,583 |
99,381,811 |
RGD:6480464 |
CTD |
| G |
DAPK1 |
death-associated protein kinase 1 |
|
increases methylation |
EXP |
9 |
90,112,756 |
90,323,549 |
RGD:6480464 |
CTD |
| G |
DCN |
decorin |
|
increases expression |
ISO |
12 |
91,539,035 |
91,576,806 |
RGD:6480464 |
CTD |
| G |
DDAH1 |
dimethylarginine dimethylaminohydrolase 1 |
|
increases expression |
ISO |
1 |
85,784,168 |
86,044,046 |
RGD:6480464 |
CTD |
| G |
DKC1 |
dyskeratosis congenita 1, dyskerin |
|
increases expression |
ISO |
X |
153,991,031 |
154,005,964 |
RGD:6480464 |
CTD |
| G |
DMBT1 |
deleted in malignant brain tumors 1 |
|
increases expression |
ISO |
10 |
124,320,181 |
124,403,252 |
RGD:6480464 |
CTD |
| G |
DPYD |
dihydropyrimidine dehydrogenase |
|
decreases expression |
ISO |
1 |
97,543,299 |
98,386,615 |
RGD:6480464 |
CTD |
| G |
DUSP6 |
dual specificity phosphatase 6 |
|
decreases expression |
ISO |
12 |
89,741,837 |
89,746,296 |
RGD:6480464 |
CTD |
| G |
DUT |
deoxyuridine triphosphatase |
|
increases expression |
ISO |
15 |
48,623,621 |
48,635,570 |
RGD:6480464 |
CTD |
| G |
EEF1G |
eukaryotic translation elongation factor 1 gamma |
|
increases expression |
ISO |
11 |
62,327,073 |
62,341,460 |
RGD:6480464 |
CTD |
| G |
EEF2 |
eukaryotic translation elongation factor 2 |
|
increases expression |
ISO |
19 |
3,976,054 |
3,985,461 |
RGD:6480464 |
CTD |
| G |
EGFR |
epidermal growth factor receptor |
|
increases phosphorylation |
EXP |
7 |
55,086,725 |
55,275,031 |
RGD:6480464 |
CTD |
| G |
EGFR |
epidermal growth factor receptor |
|
multiple interactions |
EXP |
7 |
55,086,725 |
55,275,031 |
RGD:6480464 |
CTD |
| G |
EIF4EBP1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
increases expression |
ISO |
8 |
37,888,020 |
37,917,883 |
RGD:6480464 |
CTD |
| G |
EIF4EBP1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
multiple interactions |
EXP |
8 |
37,888,020 |
37,917,883 |
RGD:6480464 |
CTD |
| G |
EPHX1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
increases expression |
ISO |
1 |
225,997,797 |
226,033,264 |
RGD:6480464 |
CTD |
| G |
EPHX1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
increases expression |
ISO |
1 |
225,997,797 |
226,033,264 |
RGD:6480464 |
CTD |
| G |
EPHX1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
increases expression |
ISO |
1 |
225,997,797 |
226,033,264 |
RGD:6480464 |
CTD |
| G |
FAM162A |
family with sequence similarity 162, member A |
|
increases expression |
ISO |
3 |
122,103,023 |
122,128,961 |
RGD:6480464 |
CTD |
| G |
FASN |
fatty acid synthase |
|
increases expression |
ISO |
17 |
80,036,214 |
80,056,106 |
RGD:6480464 |
CTD |
| G |
FKBP4 |
FK506 binding protein 4, 59kDa |
|
increases expression |
ISO |
12 |
2,904,108 |
2,914,589 |
RGD:6480464 |
CTD |
| G |
FN1 |
fibronectin 1 |
|
decreases expression |
ISO |
2 |
216,225,177 |
216,300,791 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
decreases expression |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FTH1 |
ferritin, heavy polypeptide 1 |
|
multiple interactions |
EXP |
11 |
61,731,757 |
61,735,132 |
RGD:6480464 |
CTD |
| G |
FXYD3 |
FXYD domain containing ion transport regulator 3 |
|
multiple interactions |
EXP |
19 |
35,606,732 |
35,615,228 |
RGD:6480464 |
CTD |
| G |
GADD45A |
growth arrest and DNA-damage-inducible, alpha |
|
increases expression |
ISO |
1 |
68,150,860 |
68,154,021 |
RGD:6480464 |
CTD |
| G |
GAS6 |
growth arrest-specific 6 |
|
increases expression |
ISO |
13 |
114,523,522 |
114,567,046 |
RGD:6480464 |
CTD |
| G |
GAS6 |
growth arrest-specific 6 |
|
increases expression |
ISO |
13 |
114,523,522 |
114,567,046 |
RGD:6480464 |
CTD |
| G |
GATA3 |
GATA binding protein 3 |
|
increases expression |
EXP |
10 |
8,096,667 |
8,117,164 |
RGD:6480464 |
CTD |
| G |
GATA3 |
GATA binding protein 3 |
|
increases expression |
EXP |
10 |
8,096,667 |
8,117,164 |
RGD:6480464 |
CTD |
| G |
GATA3 |
GATA binding protein 3 |
|
multiple interactions |
EXP |
10 |
8,096,667 |
8,117,164 |
RGD:6480464 |
CTD |
| G |
GATA3 |
GATA binding protein 3 |
|
increases activity |
EXP |
10 |
8,096,667 |
8,117,164 |
RGD:6480464 |
CTD |
| G |
GCLC |
glutamate-cysteine ligase, catalytic subunit |
|
increases expression |
ISO |
6 |
53,362,139 |
53,409,927 |
RGD:6480464 |
CTD |
| G |
GDF15 |
growth differentiation factor 15 |
|
increases expression |
ISO |
19 |
18,496,968 |
18,499,986 |
RGD:6480464 |
CTD |
| G |
GDF15 |
growth differentiation factor 15 |
|
increases expression |
ISO |
19 |
18,496,968 |
18,499,986 |
RGD:6480464 |
CTD |
| G |
GDF15 |
growth differentiation factor 15 |
|
increases expression |
ISO |
19 |
18,496,968 |
18,499,986 |
RGD:6480464 |
CTD |
| G |
GLS2 |
glutaminase 2 (liver, mitochondrial) |
|
decreases expression |
ISO |
12 |
56,864,736 |
56,882,181 |
RGD:6480464 |
CTD |
| G |
GNMT |
glycine N-methyltransferase |
|
decreases expression |
ISO |
6 |
42,928,500 |
42,931,618 |
RGD:6480464 |
CTD |
| G |
GRIA3 |
glutamate receptor, ionotropic, AMPA 3 |
|
increases expression |
ISO |
X |
122,318,096 |
122,624,766 |
RGD:6480464 |
CTD |
| G |
GRPEL1 |
GrpE-like 1, mitochondrial (E. coli) |
|
increases expression |
ISO |
4 |
7,061,780 |
7,069,800 |
RGD:6480464 |
CTD |
| G |
GSK3A |
glycogen synthase kinase 3 alpha |
|
multiple interactions |
EXP |
19 |
42,734,338 |
42,746,736 |
RGD:6480464 |
CTD |
| G |
GSK3B |
glycogen synthase kinase 3 beta |
|
multiple interactions |
EXP |
3 |
119,540,800 |
119,813,264 |
RGD:6480464 |
CTD |
| G |
GSR |
glutathione reductase |
|
increases expression |
ISO |
8 |
30,535,578 |
30,585,486 |
RGD:6480464 |
CTD |
| G |
GSS |
glutathione synthetase |
|
increases expression |
ISO |
20 |
33,516,236 |
33,543,601 |
RGD:6480464 |
CTD |
| G |
GSTA2 |
glutathione S-transferase alpha 2 |
|
increases expression |
ISO |
6 |
52,614,885 |
52,628,361 |
RGD:6480464 |
CTD |
| G |
GSTA4 |
glutathione S-transferase alpha 4 |
|
decreases expression |
ISO |
6 |
52,842,746 |
52,860,178 |
RGD:6480464 |
CTD |
| G |
GSTA4 |
glutathione S-transferase alpha 4 |
|
increases activity |
ISO |
6 |
52,842,746 |
52,860,178 |
RGD:6480464 |
CTD |
| G |
GSTA4 |
glutathione S-transferase alpha 4 |
|
increases expression |
ISO |
6 |
52,842,746 |
52,860,178 |
RGD:6480464 |
CTD |
| G |
GSTA5 |
glutathione S-transferase alpha 5 |
|
increases expression |
ISO |
6 |
52,696,540 |
52,710,893 |
RGD:6480464 |
CTD |
| G |
GSTA5 |
glutathione S-transferase alpha 5 |
|
increases expression |
ISO |
6 |
52,696,540 |
52,710,893 |
RGD:6480464 |
CTD |
| G |
GTPBP1 |
GTP binding protein 1 |
|
decreases expression |
EXP |
22 |
39,101,807 |
39,129,592 |
RGD:6480464 |
CTD |
| G |
H2AFX |
H2A histone family, member X |
|
increases expression |
ISO |
11 |
118,964,584 |
118,966,177 |
RGD:6480464 |
CTD |
| G |
H2AFX |
H2A histone family, member X |
|
multiple interactions |
EXP |
11 |
118,964,584 |
118,966,177 |
RGD:6480464 |
CTD |
| G |
H2AFZ |
H2A histone family, member Z |
|
decreases expression |
ISO |
4 |
100,869,244 |
100,871,512 |
RGD:6480464 |
CTD |
| G |
HBA2 |
hemoglobin, alpha 2 |
|
multiple interactions |
EXP |
16 |
222,846 |
223,709 |
RGD:6480464 |
CTD |
| G |
HCRTR2 |
hypocretin (orexin) receptor 2 |
|
increases expression |
EXP |
6 |
55,039,071 |
55,147,418 |
RGD:6480464 |
CTD |
| G |
HDC |
histidine decarboxylase |
|
increases expression |
ISO |
15 |
50,534,144 |
50,558,162 |
RGD:6480464 |
CTD |
| G |
HIST3H3 |
histone cluster 3, H3 |
|
increases expression |
EXP |
1 |
228,612,546 |
228,613,026 |
RGD:6480464 |
CTD |
| G |
HLA-DQB1 |
major histocompatibility complex, class II, DQ beta 1 |
|
increases expression |
ISO |
6 |
32,627,241 |
32,634,466 |
RGD:6480464 |
CTD |
| G |
HMGB2 |
high mobility group box 2 |
|
decreases expression |
ISO |
4 |
174,252,527 |
174,255,595 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HPRT1 |
hypoxanthine phosphoribosyltransferase 1 |
|
multiple interactions |
ISO |
X |
133,594,175 |
133,634,698 |
RGD:6480464 |
CTD |
| G |
HPRT1 |
hypoxanthine phosphoribosyltransferase 1 |
|
increases mutagenesis |
ISO |
X |
133,594,175 |
133,634,698 |
RGD:6480464 |
CTD |
| G |
HSD11B2 |
hydroxysteroid (11-beta) dehydrogenase 2 |
|
multiple interactions |
EXP |
16 |
67,465,036 |
67,471,456 |
RGD:6480464 |
CTD |
| G |
HSF1 |
heat shock transcription factor 1 |
|
increases expression |
ISO |
8 |
145,515,270 |
145,538,385 |
RGD:6480464 |
CTD |
| G |
HSPA9 |
heat shock 70kDa protein 9 (mortalin) |
|
increases expression |
ISO |
5 |
137,890,571 |
137,911,318 |
RGD:6480464 |
CTD |
| G |
HSPB1 |
heat shock 27kDa protein 1 |
|
increases expression |
ISO |
7 |
75,931,875 |
75,933,614 |
RGD:6480464 |
CTD |
| G |
HSPE1 |
heat shock 10kDa protein 1 (chaperonin 10) |
|
increases expression |
ISO |
2 |
198,364,721 |
198,368,187 |
RGD:6480464 |
CTD |
| G |
HSPH1 |
heat shock 105kDa/110kDa protein 1 |
|
increases expression |
ISO |
13 |
31,710,762 |
31,736,117 |
RGD:6480464 |
CTD |
| G |
IDE |
insulin-degrading enzyme |
|
increases expression |
ISO |
10 |
94,211,441 |
94,333,852 |
RGD:6480464 |
CTD |
| G |
IGFBP1 |
insulin-like growth factor binding protein 1 |
|
increases expression |
ISO |
7 |
45,927,959 |
45,933,267 |
RGD:6480464 |
CTD |
| G |
IGFBP2 |
insulin-like growth factor binding protein 2, 36kDa |
|
increases expression |
ISO |
2 |
217,498,127 |
217,529,159 |
RGD:6480464 |
CTD |
| G |
IGFBP2 |
insulin-like growth factor binding protein 2, 36kDa |
|
increases expression |
ISO |
2 |
217,498,127 |
217,529,159 |
RGD:6480464 |
CTD |
| G |
IGFBP3 |
insulin-like growth factor binding protein 3 |
|
decreases expression |
ISO |
7 |
45,951,844 |
45,960,871 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
decreases expression |
EXP |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
decreases expression |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
INMT |
indolethylamine N-methyltransferase |
|
decreases expression |
ISO |
7 |
30,791,751 |
30,797,218 |
RGD:6480464 |
CTD |
| G |
INTS4 |
integrator complex subunit 4 |
|
increases expression |
ISO |
11 |
77,589,766 |
77,705,717 |
RGD:6480464 |
CTD |
| G |
IRF1 |
interferon regulatory factor 1 |
|
increases expression |
ISO |
5 |
131,817,301 |
131,826,465 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
decreases expression |
ISO |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
multiple interactions |
ISO |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
KRAS |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
increases mutagenesis |
ISO |
12 |
25,358,180 |
25,403,854 |
RGD:6480464 |
CTD |
| G |
KRAS |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
12 |
25,358,180 |
25,403,854 |
RGD:6480464 |
CTD |
| G |
KRT15 |
keratin 15 |
|
multiple interactions |
EXP |
17 |
39,669,997 |
39,675,270 |
RGD:6480464 |
CTD |
| G |
LAMA5 |
laminin, alpha 5 |
|
increases expression |
ISO |
20 |
60,884,121 |
60,942,368 |
RGD:6480464 |
CTD |
| G |
LGALS3 |
lectin, galactoside-binding, soluble, 3 |
|
increases expression |
ISO |
14 |
55,595,935 |
55,612,148 |
RGD:6480464 |
CTD |
| G |
LTB4R |
leukotriene B4 receptor |
|
decreases expression |
EXP |
14 |
24,780,705 |
24,787,242 |
RGD:6480464 |
CTD |
| G |
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
|
multiple interactions |
EXP |
15 |
66,679,211 |
66,783,882 |
RGD:6480464 |
CTD |
| G |
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
|
multiple interactions |
EXP |
19 |
4,090,319 |
4,124,126 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
increases phosphorylation |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
increases phosphorylation |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
increases activity |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
increases phosphorylation |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
increases activity |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
increases phosphorylation |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAT1A |
methionine adenosyltransferase I, alpha |
|
decreases expression |
ISO |
10 |
82,031,576 |
82,049,434 |
RGD:6480464 |
CTD |
| G |
MCAM |
melanoma cell adhesion molecule |
|
decreases expression |
ISO |
11 |
119,179,234 |
119,187,840 |
RGD:6480464 |
CTD |
| G |
MCM6 |
minichromosome maintenance complex component 6 |
|
increases expression |
ISO |
2 |
136,597,196 |
136,634,047 |
RGD:6480464 |
CTD |
| G |
MDM2 |
MDM2 oncogene, E3 ubiquitin protein ligase |
|
increases expression |
ISO |
12 |
69,201,971 |
69,239,320 |
RGD:6480464 |
CTD |
| G |
MDM2 |
MDM2 oncogene, E3 ubiquitin protein ligase |
|
increases expression |
ISO |
12 |
69,201,971 |
69,239,320 |
RGD:6480464 |
CTD |
| G |
MDM2 |
MDM2 oncogene, E3 ubiquitin protein ligase |
|
increases expression |
ISO |
12 |
69,201,971 |
69,239,320 |
RGD:6480464 |
CTD |
| G |
MDM2 |
MDM2 oncogene, E3 ubiquitin protein ligase |
|
increases expression |
ISO |
12 |
69,201,971 |
69,239,320 |
RGD:6480464 |
CTD |
| G |
MGMT |
O-6-methylguanine-DNA methyltransferase |
|
increases expression |
ISO |
10 |
131,265,454 |
131,565,783 |
RGD:6480464 |
CTD |
| G |
MGMT |
O-6-methylguanine-DNA methyltransferase |
|
increases expression |
ISO |
10 |
131,265,454 |
131,565,783 |
RGD:6480464 |
CTD |
| G |
MGMT |
O-6-methylguanine-DNA methyltransferase |
|
increases expression |
ISO |
10 |
131,265,454 |
131,565,783 |
RGD:6480464 |
CTD |
| G |
MGMT |
O-6-methylguanine-DNA methyltransferase |
|
increases expression |
ISO |
10 |
131,265,454 |
131,565,783 |
RGD:6480464 |
CTD |
| G |
MIS18A |
MIS18 kinetochore protein homolog A (S. pombe) |
|
increases expression |
EXP |
21 |
33,640,530 |
33,651,376 |
RGD:6480464 |
CTD |
| G |
MKI67 |
antigen identified by monoclonal antibody Ki-67 |
|
increases expression |
EXP |
10 |
129,894,923 |
129,924,468 |
RGD:6480464 |
CTD |
| G |
MMP9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
|
decreases expression |
ISO |
20 |
44,637,547 |
44,645,200 |
RGD:6480464 |
CTD |
| G |
MMP9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
|
multiple interactions |
ISO |
20 |
44,637,547 |
44,645,200 |
RGD:6480464 |
CTD |
| G |
MRPL41 |
mitochondrial ribosomal protein L41 |
|
multiple interactions |
EXP |
9 |
140,446,309 |
140,447,007 |
RGD:6480464 |
CTD |
| G |
MT1A |
metallothionein 1A |
|
decreases expression |
ISO |
16 |
56,672,578 |
56,673,999 |
RGD:6480464 |
CTD |
| G |
MT1A |
metallothionein 1A |
|
decreases expression |
ISO |
16 |
56,672,578 |
56,673,999 |
RGD:6480464 |
CTD |
| G |
MT1E |
metallothionein 1E |
|
multiple interactions |
EXP |
16 |
56,659,585 |
56,661,024 |
RGD:6480464 |
CTD |
| G |
MT1F |
metallothionein 1F |
|
increases expression |
EXP |
16 |
56,691,855 |
56,693,215 |
RGD:6480464 |
CTD |
| G |
MT2A |
metallothionein 2A |
|
decreases expression |
ISO |
16 |
56,642,478 |
56,643,409 |
RGD:6480464 |
CTD |
| G |
MT2A |
metallothionein 2A |
|
decreases expression |
ISO |
16 |
56,642,478 |
56,643,409 |
RGD:6480464 |
CTD |
| G |
MTA2 |
metastasis associated 1 family, member 2 |
|
decreases expression |
ISO |
11 |
62,360,675 |
62,369,312 |
RGD:6480464 |
CTD |
| G |
MYC |
v-myc myelocytomatosis viral oncogene homolog (avian) |
|
increases activity |
EXP |
8 |
128,748,315 |
128,753,680 |
RGD:6480464 |
CTD |
| G |
MYC |
v-myc myelocytomatosis viral oncogene homolog (avian) |
|
increases expression |
ISO |
8 |
128,748,315 |
128,753,680 |
RGD:6480464 |
CTD |
| G |
NAP1L1 |
nucleosome assembly protein 1-like 1 |
|
increases expression |
ISO |
12 |
76,438,672 |
76,478,738 |
RGD:6480464 |
CTD |
| G |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
increases activity |
EXP |
4 |
103,422,486 |
103,538,459 |
RGD:6480464 |
CTD |
| G |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
increases expression |
EXP |
4 |
103,422,486 |
103,538,459 |
RGD:6480464 |
CTD |
| G |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
EXP |
4 |
103,422,486 |
103,538,459 |
RGD:6480464 |
CTD |
| G |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
EXP |
4 |
103,422,486 |
103,538,459 |
RGD:6480464 |
CTD |
| G |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
increases expression |
EXP |
4 |
103,422,486 |
103,538,459 |
RGD:6480464 |
CTD |
| G |
NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases phosphorylation |
EXP |
14 |
35,870,716 |
35,873,960 |
RGD:6480464 |
CTD |
| G |
NHEJ1 |
nonhomologous end-joining factor 1 |
|
increases expression |
ISO |
2 |
219,940,046 |
220,025,587 |
RGD:6480464 |
CTD |
| G |
NPC1 |
Niemann-Pick disease, type C1 |
|
increases expression |
EXP |
18 |
21,111,463 |
21,166,581 |
RGD:6480464 |
CTD |
| G |
NPM1 |
nucleophosmin (nucleolar phosphoprotein B23, numatrin) |
|
increases expression |
ISO |
5 |
170,814,708 |
170,837,888 |
RGD:6480464 |
CTD |
| G |
NQO1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
16 |
69,743,304 |
69,760,533 |
RGD:6480464 |
CTD |
| G |
NQO1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
16 |
69,743,304 |
69,760,533 |
RGD:6480464 |
CTD |
| G |
NRCAM |
neuronal cell adhesion molecule |
|
increases expression |
ISO |
7 |
107,788,071 |
108,096,841 |
RGD:6480464 |
CTD |
| G |
NRG1 |
neuregulin 1 |
|
increases expression |
ISO |
8 |
31,496,820 |
32,622,558 |
RGD:6480464 |
CTD |
| G |
NRG1 |
neuregulin 1 |
|
increases expression |
ISO |
8 |
31,496,820 |
32,622,558 |
RGD:6480464 |
CTD |
| G |
NRG1 |
neuregulin 1 |
|
increases expression |
ISO |
8 |
31,496,820 |
32,622,558 |
RGD:6480464 |
CTD |
| G |
NUBPL |
nucleotide binding protein-like |
|
decreases expression |
ISO |
14 |
32,030,591 |
32,330,430 |
RGD:6480464 |
CTD |
| G |
NUPR1 |
nuclear protein, transcriptional regulator, 1 |
|
decreases expression |
ISO |
16 |
28,548,662 |
28,550,495 |
RGD:6480464 |
CTD |
| G |
NUPR1 |
nuclear protein, transcriptional regulator, 1 |
|
decreases expression |
ISO |
16 |
28,548,662 |
28,550,495 |
RGD:6480464 |
CTD |
| G |
OAT |
ornithine aminotransferase |
|
decreases expression |
ISO |
10 |
126,085,872 |
126,107,545 |
RGD:6480464 |
CTD |
| G |
OAT |
ornithine aminotransferase |
|
decreases expression |
ISO |
10 |
126,085,872 |
126,107,545 |
RGD:6480464 |
CTD |
| G |
ODC1 |
ornithine decarboxylase 1 |
|
increases activity |
ISO |
2 |
10,580,508 |
10,588,453 |
RGD:6480464 |
CTD |
| G |
ODC1 |
ornithine decarboxylase 1 |
|
increases expression |
ISO |
2 |
10,580,508 |
10,588,453 |
RGD:6480464 |
CTD |
| G |
ODC1 |
ornithine decarboxylase 1 |
|
multiple interactions |
ISO |
2 |
10,580,508 |
10,588,453 |
RGD:6480464 |
CTD |
| G |
ODC1 |
ornithine decarboxylase 1 |
|
increases expression |
ISO |
2 |
10,580,508 |
10,588,453 |
RGD:6480464 |
CTD |
| G |
PCNA |
proliferating cell nuclear antigen |
|
increases expression |
EXP |
20 |
5,095,599 |
5,107,268 |
RGD:6480464 |
CTD |
| G |
PCNA |
proliferating cell nuclear antigen |
|
multiple interactions |
EXP |
20 |
5,095,599 |
5,107,268 |
RGD:6480464 |
CTD |
| G |
PCNA |
proliferating cell nuclear antigen |
|
increases expression |
ISO |
20 |
5,095,599 |
5,107,268 |
RGD:6480464 |
CTD |
| G |
PCNA |
proliferating cell nuclear antigen |
|
increases expression |
EXP |
20 |
5,095,599 |
5,107,268 |
RGD:6480464 |
CTD |
| G |
PCSK2 |
proprotein convertase subtilisin/kexin type 2 |
|
multiple interactions |
EXP |
20 |
17,206,752 |
17,465,223 |
RGD:6480464 |
CTD |
| G |
PDCD4 |
programmed cell death 4 (neoplastic transformation inhibitor) |
|
decreases expression |
EXP |
10 |
112,631,553 |
112,659,764 |
RGD:6480464 |
CTD |
| G |
PER1 |
period circadian clock 1 |
|
multiple interactions |
EXP |
17 |
8,043,788 |
8,055,753 |
RGD:6480464 |
CTD |
| G |
PGD |
phosphogluconate dehydrogenase |
|
decreases expression |
EXP |
1 |
10,459,085 |
10,480,201 |
RGD:6480464 |
CTD |
| G |
PHGDH |
phosphoglycerate dehydrogenase |
|
increases expression |
ISO |
1 |
120,254,419 |
120,286,849 |
RGD:6480464 |
CTD |
| G |
PHLDA3 |
pleckstrin homology-like domain, family A, member 3 |
|
increases expression |
ISO |
1 |
201,434,607 |
201,438,299 |
RGD:6480464 |
CTD |
| G |
PHLDA3 |
pleckstrin homology-like domain, family A, member 3 |
|
increases expression |
ISO |
1 |
201,434,607 |
201,438,299 |
RGD:6480464 |
CTD |
| G |
PLAU |
plasminogen activator, urokinase |
|
decreases expression |
ISO |
10 |
75,670,862 |
75,677,259 |
RGD:6480464 |
CTD |
| G |
PLAU |
plasminogen activator, urokinase |
|
multiple interactions |
ISO |
10 |
75,670,862 |
75,677,259 |
RGD:6480464 |
CTD |
| G |
PLK2 |
polo-like kinase 2 |
|
increases expression |
ISO |
5 |
57,749,809 |
57,755,966 |
RGD:6480464 |
CTD |
| G |
PLN |
phospholamban |
|
increases expression |
ISO |
6 |
118,869,442 |
118,881,587 |
RGD:6480464 |
CTD |
| G |
POR |
P450 (cytochrome) oxidoreductase |
|
affects response to substance |
ISO |
7 |
75,544,420 |
75,616,173 |
RGD:6480464 |
CTD |
| G |
PSMA1 |
proteasome (prosome, macropain) subunit, alpha type, 1 |
|
increases expression |
ISO |
11 |
14,526,422 |
14,665,180 |
RGD:6480464 |
CTD |
| G |
PSMA2 |
proteasome (prosome, macropain) subunit, alpha type, 2 |
|
increases expression |
ISO |
7 |
42,956,460 |
42,971,805 |
RGD:6480464 |
CTD |
| G |
PSMA4 |
proteasome (prosome, macropain) subunit, alpha type, 4 |
|
increases expression |
ISO |
15 |
78,832,747 |
78,841,562 |
RGD:6480464 |
CTD |
| G |
PSMA5 |
proteasome (prosome, macropain) subunit, alpha type, 5 |
|
decreases expression |
ISO |
1 |
109,941,653 |
109,969,108 |
RGD:6480464 |
CTD |
| G |
PSMA7 |
proteasome (prosome, macropain) subunit, alpha type, 7 |
|
increases expression |
ISO |
20 |
60,711,783 |
60,718,514 |
RGD:6480464 |
CTD |
| G |
PSMB1 |
proteasome (prosome, macropain) subunit, beta type, 1 |
|
increases expression |
ISO |
6 |
170,844,204 |
170,862,417 |
RGD:6480464 |
CTD |
| G |
PSMB3 |
proteasome (prosome, macropain) subunit, beta type, 3 |
|
increases expression |
ISO |
17 |
36,909,002 |
36,920,478 |
RGD:6480464 |
CTD |
| G |
PSMB4 |
proteasome (prosome, macropain) subunit, beta type, 4 |
|
increases expression |
ISO |
1 |
151,372,041 |
151,374,412 |
RGD:6480464 |
CTD |
| G |
PSMB5 |
proteasome (prosome, macropain) subunit, beta type, 5 |
|
increases expression |
ISO |
14 |
23,495,060 |
23,504,429 |
RGD:6480464 |
CTD |
| G |
PSMC1 |
proteasome (prosome, macropain) 26S subunit, ATPase, 1 |
|
increases expression |
ISO |
14 |
90,722,894 |
90,738,966 |
RGD:6480464 |
CTD |
| G |
PSMC2 |
proteasome (prosome, macropain) 26S subunit, ATPase, 2 |
|
increases expression |
ISO |
7 |
102,987,971 |
103,009,842 |
RGD:6480464 |
CTD |
| G |
PSMC4 |
proteasome (prosome, macropain) 26S subunit, ATPase, 4 |
|
increases expression |
ISO |
19 |
40,476,912 |
40,487,671 |
RGD:6480464 |
CTD |
| G |
PSMC5 |
proteasome (prosome, macropain) 26S subunit, ATPase, 5 |
|
increases expression |
ISO |
17 |
61,904,770 |
61,909,387 |
RGD:6480464 |
CTD |
| G |
PSMD1 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 1 |
|
increases expression |
ISO |
2 |
231,921,578 |
232,037,541 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
EXP |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
increases activity |
EXP |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
increases activity |
EXP |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTP4A1 |
protein tyrosine phosphatase type IVA, member 1 |
|
increases expression |
ISO |
6 |
64,281,920 |
64,293,489 |
RGD:6480464 |
CTD |
| G |
PTPRVP |
protein tyrosine phosphatase, receptor type, V, pseudogene |
|
increases expression |
ISO |
1 |
202,137,179 |
202,158,577 |
RGD:6480464 |
CTD |
| G |
PTTG1 |
pituitary tumor-transforming 1 |
|
decreases expression |
ISO |
5 |
159,848,865 |
159,855,746 |
RGD:6480464 |
CTD |
| G |
R3HDM2 |
R3H domain containing 2 |
|
decreases expression |
ISO |
12 |
57,647,548 |
57,704,246 |
RGD:6480464 |
CTD |
| G |
RAD23B |
RAD23 homolog B (S. cerevisiae) |
|
decreases expression |
EXP |
9 |
110,045,517 |
110,094,475 |
RGD:6480464 |
CTD |
| G |
RAF1 |
v-raf-1 murine leukemia viral oncogene homolog 1 |
|
increases activity |
EXP |
3 |
12,625,100 |
12,705,700 |
RGD:6480464 |
CTD |
| G |
RARB |
retinoic acid receptor, beta |
|
increases methylation |
ISO |
3 |
25,469,754 |
25,639,423 |
RGD:6480464 |
CTD |
| G |
RB1 |
retinoblastoma 1 |
|
multiple interactions |
EXP |
13 |
48,877,883 |
49,056,026 |
RGD:6480464 |
CTD |
| G |
RB1 |
retinoblastoma 1 |
|
increases phosphorylation |
EXP |
13 |
48,877,883 |
49,056,026 |
RGD:6480464 |
CTD |
| G |
RB1 |
retinoblastoma 1 |
|
decreases expression |
ISO |
13 |
48,877,883 |
49,056,026 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RFX1 |
regulatory factor X, 1 (influences HLA class II expression) |
|
increases expression |
EXP |
19 |
14,072,342 |
14,117,134 |
RGD:6480464 |
CTD |
| G |
RGMB |
RGM domain family, member B |
|
multiple interactions |
EXP |
5 |
98,104,999 |
98,132,198 |
RGD:6480464 |
CTD |
| G |
RHCG |
Rh family, C glycoprotein |
|
decreases expression |
EXP |
15 |
90,014,638 |
90,039,799 |
RGD:6480464 |
CTD |
| G |
RHEB |
Ras homolog enriched in brain |
|
increases expression |
ISO |
7 |
151,163,098 |
151,217,010 |
RGD:6480464 |
CTD |
| G |
RHOB |
ras homolog family member B |
|
increases expression |
ISO |
2 |
20,646,835 |
20,649,201 |
RGD:6480464 |
CTD |
| G |
RHOB |
ras homolog family member B |
|
increases expression |
ISO |
2 |
20,646,835 |
20,649,201 |
RGD:6480464 |
CTD |
| G |
RPL10 |
ribosomal protein L10 |
|
increases expression |
ISO |
X |
153,626,571 |
153,630,680 |
RGD:6480464 |
CTD |
| G |
RPL10A |
ribosomal protein L10a |
|
increases expression |
ISO |
6 |
35,436,178 |
35,438,558 |
RGD:6480464 |
CTD |
| G |
RPL13 |
ribosomal protein L13 |
|
increases expression |
ISO |
16 |
89,627,065 |
89,633,237 |
RGD:6480464 |
CTD |
| G |
RPL15 |
ribosomal protein L15 |
|
increases expression |
ISO |
3 |
23,958,295 |
23,965,187 |
RGD:6480464 |
CTD |
| G |
RPL17 |
ribosomal protein L17 |
|
increases expression |
ISO |
18 |
47,014,851 |
47,018,935 |
RGD:6480464 |
CTD |
| G |
RPL17 |
ribosomal protein L17 |
|
increases expression |
ISO |
18 |
47,014,851 |
47,018,935 |
RGD:6480464 |
CTD |
| G |
RPL23 |
ribosomal protein L23 |
|
increases expression |
ISO |
17 |
37,006,321 |
37,010,053 |
RGD:6480464 |
CTD |
| G |
RPL6 |
ribosomal protein L6 |
|
increases expression |
ISO |
12 |
112,842,994 |
112,847,443 |
RGD:6480464 |
CTD |
| G |
RPL7A |
ribosomal protein L7a |
|
increases expression |
ISO |
9 |
136,215,069 |
136,218,280 |
RGD:6480464 |
CTD |
| G |
RPL7A |
ribosomal protein L7a |
|
increases expression |
ISO |
9 |
136,215,069 |
136,218,280 |
RGD:6480464 |
CTD |
| G |
RPL8 |
ribosomal protein L8 |
|
increases expression |
ISO |
8 |
146,015,154 |
146,017,805 |
RGD:6480464 |
CTD |
| G |
RPS15A |
ribosomal protein S15a |
|
increases expression |
ISO |
16 |
18,794,277 |
18,801,656 |
RGD:6480464 |
CTD |
| G |
RPS19 |
ribosomal protein S19 |
|
increases expression |
ISO |
19 |
42,363,988 |
42,375,484 |
RGD:6480464 |
CTD |
| G |
RPS19 |
ribosomal protein S19 |
|
increases expression |
ISO |
19 |
42,363,988 |
42,375,484 |
RGD:6480464 |
CTD |
| G |
RPS24 |
ribosomal protein S24 |
|
increases expression |
ISO |
10 |
79,793,518 |
79,816,571 |
RGD:6480464 |
CTD |
| G |
RPS27L |
ribosomal protein S27-like |
|
increases expression |
ISO |
15 |
63,445,539 |
63,449,741 |
RGD:6480464 |
CTD |
| G |
RPS27L |
ribosomal protein S27-like |
|
increases expression |
ISO |
15 |
63,445,539 |
63,449,741 |
RGD:6480464 |
CTD |
| G |
RPS27L |
ribosomal protein S27-like |
|
increases expression |
ISO |
15 |
63,445,539 |
63,449,741 |
RGD:6480464 |
CTD |
| G |
RPS3 |
ribosomal protein S3 |
|
increases expression |
ISO |
11 |
75,110,535 |
75,133,346 |
RGD:6480464 |
CTD |
| G |
RPS4X |
ribosomal protein S4, X-linked |
|
increases expression |
ISO |
X |
71,492,453 |
71,497,141 |
RGD:6480464 |
CTD |
| G |
RPS7 |
ribosomal protein S7 |
|
increases expression |
ISO |
2 |
3,622,853 |
3,628,509 |
RGD:6480464 |
CTD |
| G |
RPSA |
ribosomal protein SA |
|
increases expression |
ISO |
3 |
39,448,204 |
39,454,033 |
RGD:6480464 |
CTD |
| G |
S100A4 |
S100 calcium binding protein A4 |
|
decreases expression |
ISO |
1 |
153,516,095 |
153,518,282 |
RGD:6480464 |
CTD |
| G |
S100A4 |
S100 calcium binding protein A4 |
|
multiple interactions |
ISO |
1 |
153,516,095 |
153,518,282 |
RGD:6480464 |
CTD |
| G |
S100P |
S100 calcium binding protein P |
|
multiple interactions |
EXP |
4 |
6,695,566 |
6,698,897 |
RGD:6480464 |
CTD |
| G |
SDS |
serine dehydratase |
|
decreases expression |
ISO |
12 |
113,830,250 |
113,841,692 |
RGD:6480464 |
CTD |
| G |
SELO |
selenoprotein O |
|
increases expression |
EXP |
22 |
50,639,408 |
50,656,045 |
RGD:6480464 |
CTD |
| G |
SEPW1 |
selenoprotein W, 1 |
|
increases expression |
ISO |
19 |
48,281,842 |
48,287,939 |
RGD:6480464 |
CTD |
| G |
SERPINA7 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 |
|
increases expression |
ISO |
X |
105,277,190 |
105,282,718 |
RGD:6480464 |
CTD |
| G |
SLC9A9 |
solute carrier family 9, subfamily A (NHE9, cation proton antiporter 9), member 9 |
|
decreases expression |
EXP |
3 |
142,984,064 |
143,567,373 |
RGD:6480464 |
CTD |
| G |
SMG1 |
smg-1 homolog, phosphatidylinositol 3-kinase-related kinase (C. elegans) |
|
increases expression |
EXP |
16 |
18,816,175 |
18,937,726 |
RGD:6480464 |
CTD |
| G |
SMOC1 |
SPARC related modular calcium binding 1 |
|
increases expression |
EXP |
14 |
70,346,114 |
70,499,083 |
RGD:6480464 |
CTD |
| G |
SOAT2 |
sterol O-acyltransferase 2 |
|
decreases expression |
EXP |
12 |
53,497,274 |
53,518,323 |
RGD:6480464 |
CTD |
| G |
SPRR1B |
small proline-rich protein 1B |
|
multiple interactions |
EXP |
1 |
153,003,679 |
153,005,376 |
RGD:6480464 |
CTD |
| G |
SPTAN1 |
spectrin, alpha, non-erythrocytic 1 |
|
increases expression |
ISO |
9 |
131,314,837 |
131,395,944 |
RGD:6480464 |
CTD |
| G |
STAT1 |
signal transducer and activator of transcription 1, 91kDa |
|
increases expression |
EXP |
2 |
191,833,762 |
191,878,976 |
RGD:6480464 |
CTD |
| G |
STAT1 |
signal transducer and activator of transcription 1, 91kDa |
|
increases activity |
EXP |
2 |
191,833,762 |
191,878,976 |
RGD:6480464 |
CTD |
| G |
STAT1 |
signal transducer and activator of transcription 1, 91kDa |
|
increases expression |
EXP |
2 |
191,833,762 |
191,878,976 |
RGD:6480464 |
CTD |
| G |
STAT1 |
signal transducer and activator of transcription 1, 91kDa |
|
multiple interactions |
EXP |
2 |
191,833,762 |
191,878,976 |
RGD:6480464 |
CTD |
| G |
STAT1 |
signal transducer and activator of transcription 1, 91kDa |
|
multiple interactions |
EXP |
2 |
191,833,762 |
191,878,976 |
RGD:6480464 |
CTD |
| G |
STMN1 |
stathmin 1 |
|
increases expression |
ISO |
1 |
26,210,677 |
26,233,368 |
RGD:6480464 |
CTD |
| G |
TAP1 |
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
|
increases expression |
ISO |
6 |
32,812,986 |
32,821,748 |
RGD:6480464 |
CTD |
| G |
TARS |
threonyl-tRNA synthetase |
|
increases expression |
EXP |
5 |
33,440,802 |
33,468,196 |
RGD:6480464 |
CTD |
| G |
TAT |
tyrosine aminotransferase |
|
increases expression |
ISO |
16 |
71,600,754 |
71,610,998 |
RGD:6480464 |
CTD |
| G |
TBRG4 |
transforming growth factor beta regulator 4 |
|
decreases expression |
EXP |
7 |
45,139,699 |
45,151,346 |
RGD:6480464 |
CTD |
| G |
TIMM10B |
translocase of inner mitochondrial membrane 10 homolog B (yeast) |
|
increases expression |
ISO |
11 |
6,502,677 |
6,505,911 |
RGD:6480464 |
CTD |
| G |
TIMP1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
ISO |
X |
47,441,690 |
47,446,190 |
RGD:6480464 |
CTD |
| G |
TIMP1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
ISO |
X |
47,441,690 |
47,446,190 |
RGD:6480464 |
CTD |
| G |
TMSB10 |
thymosin beta 10 |
|
increases expression |
ISO |
2 |
85,132,763 |
85,133,799 |
RGD:6480464 |
CTD |
| G |
TNFAIP3 |
tumor necrosis factor, alpha-induced protein 3 |
|
increases expression |
EXP |
6 |
138,188,325 |
138,204,451 |
RGD:6480464 |
CTD |
| G |
TNFRSF8 |
tumor necrosis factor receptor superfamily, member 8 |
|
multiple interactions |
EXP |
1 |
12,123,434 |
12,204,264 |
RGD:6480464 |
CTD |
| G |
TOP2A |
topoisomerase (DNA) II alpha 170kDa |
|
decreases expression |
ISO |
17 |
38,544,773 |
38,574,202 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
affects localization |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
affects localization |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
decreases expression |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
increases expression |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
increases phosphorylation |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
increases ADP-ribosylation |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
ISO |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
increases expression |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TPD52 |
tumor protein D52 |
|
decreases expression |
EXP |
8 |
80,947,103 |
81,083,836 |
RGD:6480464 |
CTD |
| G |
TSC22D1 |
TSC22 domain family, member 1 |
|
decreases expression |
ISO |
13 |
45,006,279 |
45,150,701 |
RGD:6480464 |
CTD |
| G |
TUBB |
tubulin, beta class I |
|
increases expression |
ISO |
6 |
30,688,157 |
30,693,199 |
RGD:6480464 |
CTD |
| G |
TWIST1 |
twist basic helix-loop-helix transcription factor 1 |
|
increases expression |
ISO |
7 |
19,155,091 |
19,157,295 |
RGD:6480464 |
CTD |
| G |
TYMS |
thymidylate synthetase |
|
increases expression |
ISO |
18 |
657,604 |
673,499 |
RGD:6480464 |
CTD |
| G |
TYMS |
thymidylate synthetase |
|
increases expression |
ISO |
18 |
657,604 |
673,499 |
RGD:6480464 |
CTD |
| G |
TYMS |
thymidylate synthetase |
|
increases expression |
ISO |
18 |
657,604 |
673,499 |
RGD:6480464 |
CTD |
| G |
UBA52 |
ubiquitin A-52 residue ribosomal protein fusion product 1 |
|
increases expression |
EXP |
19 |
18,682,614 |
18,688,270 |
RGD:6480464 |
CTD |
| G |
UBE2R2 |
ubiquitin-conjugating enzyme E2R 2 |
|
increases expression |
EXP |
9 |
33,817,182 |
33,920,401 |
RGD:6480464 |
CTD |
| G |
UGT1A4 |
UDP glucuronosyltransferase 1 family, polypeptide A4 |
|
increases glucuronidation |
EXP |
2 |
234,627,438 |
234,681,945 |
RGD:6480464 |
CTD |
| G |
UGT1A7 |
UDP glucuronosyltransferase 1 family, polypeptide A7 |
|
increases expression |
ISO |
2 |
234,590,584 |
234,681,945 |
RGD:6480464 |
CTD |
| G |
UGT2B7 |
UDP glucuronosyltransferase 2 family, polypeptide B7 |
|
decreases glucuronidation |
EXP |
4 |
69,962,193 |
69,978,705 |
RGD:6480464 |
CTD |
| G |
UGT2B7 |
UDP glucuronosyltransferase 2 family, polypeptide B7 |
|
increases glucuronidation |
EXP |
4 |
69,962,193 |
69,978,705 |
RGD:6480464 |
CTD |
| G |
VEGFA |
vascular endothelial growth factor A |
|
increases expression |
ISO |
6 |
43,737,946 |
43,754,224 |
RGD:6480464 |
CTD |
| G |
VIM |
vimentin |
|
increases expression |
ISO |
10 |
17,270,258 |
17,279,592 |
RGD:6480464 |
CTD |
| G |
XDH |
xanthine dehydrogenase |
|
decreases expression |
ISO |
2 |
31,557,188 |
31,637,611 |
RGD:6480464 |
CTD |
| G |
XPO1 |
exportin 1 (CRM1 homolog, yeast) |
|
decreases expression |
EXP |
2 |
61,705,069 |
61,765,418 |
RGD:6480464 |
CTD |
| G |
ZMAT3 |
zinc finger, matrin-type 3 |
|
increases expression |
ISO |
3 |
178,735,011 |
178,789,656 |
RGD:6480464 |
CTD |
| G |
ZMAT3 |
zinc finger, matrin-type 3 |
|
increases expression |
ISO |
3 |
178,735,011 |
178,789,656 |
RGD:6480464 |
CTD |
| G |
ZNF621 |
zinc finger protein 621 |
|
increases expression |
EXP |
3 |
40,566,376 |
40,581,043 |
RGD:6480464 |
CTD |
Term paths to the root
|